Rayonier [RYN] vs PotlatchDeltic [PCH] Detailed Stock Comparison

Rayonier
NYSE
Loading...

PotlatchDeltic
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rayonier wins in 14 metrics, PotlatchDeltic wins in 6 metrics, with 0 ties. Rayonier appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Rayonier | PotlatchDeltic | Better |
---|---|---|---|
P/E Ratio (TTM) | 10.85 | 80.19 | Rayonier |
Price-to-Book Ratio | 1.81 | 1.71 | PotlatchDeltic |
Debt-to-Equity Ratio | 45.01 | 54.97 | Rayonier |
PEG Ratio | 0.00 | -1.70 | PotlatchDeltic |
EV/EBITDA | 8.27 | 25.69 | Rayonier |
Profit Margin (TTM) | 61.39% | 3.94% | Rayonier |
Operating Margin (TTM) | 13.78% | 4.91% | Rayonier |
EBITDA Margin (TTM) | 13.78% | 4.91% | Rayonier |
Return on Equity | 18.02% | 2.07% | Rayonier |
Return on Assets (TTM) | 7.07% | 1.17% | Rayonier |
Free Cash Flow (TTM) | $159.06M | $67.47M | Rayonier |
Dividend Yield | 3.67% | 5.35% | PotlatchDeltic |
1-Year Return | -15.36% | -3.17% | PotlatchDeltic |
Price-to-Sales Ratio (TTM) | 3.39 | 3.11 | PotlatchDeltic |
Enterprise Value | $4.36B | $4.24B | Rayonier |
EV/Revenue Ratio | 3.52 | 4.02 | Rayonier |
Gross Profit Margin (TTM) | 29.69% | 12.97% | Rayonier |
Revenue per Share (TTM) | $8 | $13 | PotlatchDeltic |
Earnings per Share (Diluted) | $2.48 | $0.53 | Rayonier |
Beta (Stock Volatility) | 1.02 | 1.11 | Rayonier |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rayonier vs PotlatchDeltic Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Rayonier | -1.19% | 1.70% | 4.51% | 16.45% | -0.04% | 3.26% |
PotlatchDeltic | 0.57% | 5.67% | 4.27% | 6.39% | -0.16% | 8.62% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Rayonier | -15.36% | -14.55% | -5.81% | 17.06% | 10.84% | 50.03% |
PotlatchDeltic | -3.17% | -0.12% | -8.90% | 41.25% | 21.11% | 4.38% |
Performance & Financial Health Analysis: Rayonier vs PotlatchDeltic
Metric | RYN | PCH |
---|---|---|
Market Information | ||
Market Cap | $4.19B | $3.34B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 921,870 | 634,590 |
90 Day Avg. Volume | 1,040,337 | 563,533 |
Last Close | $26.58 | $42.70 |
52 Week Range | $21.84 - $32.88 | $36.82 - $48.12 |
% from 52W High | -19.16% | -11.26% |
All-Time High | $45.87 (Apr 18, 2022) | $65.67 (May 10, 2021) |
% from All-Time High | -42.05% | -34.98% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.07% | -0.14% |
Quarterly Earnings Growth | 213.77% | -0.46% |
Financial Health | ||
Profit Margin (TTM) | 0.61% | 0.04% |
Operating Margin (TTM) | 0.14% | 0.05% |
Return on Equity (TTM) | 0.18% | 0.02% |
Debt to Equity (MRQ) | 45.01 | 54.97 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $14.88 | $24.87 |
Cash per Share (MRQ) | $5.81 | $1.23 |
Operating Cash Flow (TTM) | $242.65M | $161.91M |
Levered Free Cash Flow (TTM) | $255.65M | $129.85M |
Dividends | ||
Last 12-Month Dividend Yield | 3.67% | 5.35% |
Last 12-Month Dividend | $0.83 | $2.25 |
Valuation & Enterprise Metrics Analysis: Rayonier vs PotlatchDeltic
Metric | RYN | PCH |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 10.85 | 80.19 |
Forward P/E | 51.73 | 53.80 |
PEG Ratio | 0.00 | -1.70 |
Price to Sales (TTM) | 3.39 | 3.11 |
Price to Book (MRQ) | 1.81 | 1.71 |
Market Capitalization | ||
Market Capitalization | $4.19B | $3.34B |
Enterprise Value | $4.36B | $4.24B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.52 | 4.02 |
Enterprise to EBITDA | 8.27 | 25.69 |
Risk & Other Metrics | ||
Beta | 1.02 | 1.11 |
Book Value per Share (MRQ) | $14.88 | $24.87 |
Financial Statements Comparison: Rayonier vs PotlatchDeltic
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | RYN | PCH |
---|---|---|
Revenue/Sales | $82.92M | $268.26M |
Cost of Goods Sold | $64.95M | $220.41M |
Gross Profit | $17.97M | $47.86M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $1.17M | $27.51M |
EBITDA | $30.03M | $52.74M |
Pre-Tax Income | $-5.30M | $25.46M |
Income Tax | $291,000 | $-344,000 |
Net Income (Profit) | $-3.09M | $25.81M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | RYN | PCH |
---|---|---|
Cash & Equivalents | $216.24M | $147.48M |
Total Current Assets | $767.39M | $294.85M |
Total Current Liabilities | $282.81M | $206.04M |
Long-Term Debt | $1.06B | $907.71M |
Total Shareholders Equity | $1.98B | $2.01B |
Retained Earnings | N/A | $-484.12M |
Property, Plant & Equipment | $18.04M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | RYN | PCH |
---|---|---|
Operating Cash Flow | $60.99M | $44.00M |
Capital Expenditures | N/A | $-12.11M |
Free Cash Flow | $43.49M | $29.52M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | $-37.57M | $-3.92M |
Short Interest & Institutional Ownership Analysis
Metric | RYN | PCH |
---|---|---|
Shares Short | 4.18M | 1.54M |
Short Ratio | 4.42 | 3.23 |
Short % of Float | 0.03% | 0.03% |
Average Daily Volume (10 Day) | 921,870 | 634,590 |
Average Daily Volume (90 Day) | 1,040,337 | 563,533 |
Shares Outstanding | 148.54M | 78.68M |
Float Shares | 138.97M | 70.72M |
% Held by Insiders | 0.01% | 0.02% |
% Held by Institutions | 0.96% | 0.95% |
Dividend Analysis & Yield Comparison: Rayonier vs PotlatchDeltic
Metric | RYN | PCH |
---|---|---|
Last 12-Month Dividend | $0.83 | $2.25 |
Last 12-Month Dividend Yield | 3.67% | 5.35% |
3-Year Avg Annual Dividend | $1.09 | $2.26 |
3-Year Avg Dividend Yield | 0.89% | 1.10% |
3-Year Total Dividends | $3.27 | $6.79 |
Ex-Dividend Date | Mar 17, 2025 | Sep 15, 2025 |